Footstar's subsidiaries and an unaffiliated investment holding company to acquire CPEX for $27.25 per share, or $71.3M in cash

CPEX Pharmaceuticals Inc.

U.S. / Small-Cap Biopharma (<$1 billion)

Seller

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Footstar Inc.

U.S. / Other

Buyer

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

UNDISCLOSED COMPANY

 

Completed

Sample

01/01/2009

announced

01/01/2009

completed